[Assessment of spasticity therapy with baclofen pump in children]

Anna Swierczyńska1

  • 1Pracownia Neurorehabilitacji, Uniwersytecki Szpital Dzieciecy w Krakowie.

Przeglad Lekarski
|October 24, 2007
PubMed

Insights

Intrathecal baclofen pump therapy effectively reduced spasticity in children with hemiparesis. This treatment improved care and mobility, with some patients regaining the ability to walk independently or with assistance.

Area of Science:

  • Pediatric Neurology
  • Rehabilitation Medicine
  • Neurosurgery

Background:

  • Spasticity in children significantly impacts motor function and daily care.
  • Baclofen pump therapy offers a targeted approach to managing severe spasticity.

Purpose of the Study:

  • To evaluate the efficacy of intrathecal baclofen pump therapy in treating spasticity in pediatric hemiparesis.
  • To assess changes in spasticity, functional status, and disability before and after pump implantation.

Main Methods:

  • A cohort of 17 pediatric patients with spastic hemiparesis was studied.
  • Spasticity was measured using the Modified Ashworth Scale.
  • Functional outcomes were assessed with the Barthel index and Rankin Scale in a subgroup.

Main Results:

  • A significant reduction in spasticity (2 points on the Modified Ashworth Scale) was observed post-implantation in 12 patients.
  • Improved ease of care and passive exercises were noted.
  • In a subgroup of 5 patients, 3 demonstrated improved ambulation, walking independently or with orthopedic support.

Conclusions:

  • Intrathecal baclofen therapy demonstrates positive outcomes in managing spasticity in pediatric hemiparesis.
  • The treatment enhances functional abilities and quality of life for affected children.
Abstract

Related Concept Videos